Singapore markets close in 6 hours 42 minutes

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.89-0.62 (-6.52%)
At close: 04:00PM EST
8.89 0.00 (0.00%)
After hours: 06:03PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
Total revenue
10,140
7,756
657
Operating expenses
Research development
154,498
182,243
63,595
Selling general and administrative
72,053
46,881
39,151
Total operating expenses
216,902
219,693
102,746
Operating income or loss
-206,762
-211,937
-102,089
Total other income/expenses net
-71
1,526
-35,409
Income before tax
-205,370
-204,472
-129,377
Income from continuing operations
-205,370
-204,472
-129,377
Net income
-205,370
-204,472
-129,377
Net income available to common shareholders
-205,370
-208,054
-130,521
Basic EPS
-
-1.04
-0.65
Diluted EPS
-
-1.04
-0.65
Basic average shares
-
200,327
200,327
Diluted average shares
-
200,327
200,327
EBITDA
-
-207,643
-100,833